Category

News
Until October 13, the deadline for you to submit your biotechnological development to the Hemisferio Biotec call is extended. The Centro de Biotecnología Traslacional (CBT) of Sofofa Hub, and the ACVC are convening companies, universities, and research centers with biotechnological developments generated and based in Chile. Projects must use biological systems and living organisms, or...
Read More
The strong momentum of national biotech companies has been partly due to the pandemic. But also due to the increased interest of investment funds in them. Innovación from El Mercurio analyzed the phenomenon. According to data from the ACVC, between 2012 and 2019, about US$ 20 million were invested in national biotech startups. But between...
Read More
For the first time, seven venture capital associations in Latin America will meet in a networking and investment meeting. The players from VC, Corporate Venture Capital, and Family Offices investing in startups will meet in Miami for two days to establish and strengthen links and learn about the investment opportunities that are taking place in...
Read More
There are four urgent laws to ensure that the country’s innovation ecosystem continues to grow. Innovation from El Mercurio analyzed where the legal gaps lie. It identified the four most relevant areas: the fintech industry, collective interest benefit companies, public purchases, and the Fund of Funds. “We are at a crucial moment in which we...
Read More
Colektia, SimpliRoute, Houm, uPlanner, Cumplo, Xepelin, PhageLab, LunarCRUSH, Camel Secure, and Anastasia – Artificial Intelligence are the Chilean startups with the most promising algorithms, considering the example of Guiseppe from NotCo. Innovación de El Mercurio asked experts to find out where the next Chilean unicorn could be. Wayra, Alaya Capital, ChileGlobal Ventures, Dadneo, Kayyak Ventures,...
Read More
  Today, August 24, BioHunt was held. An event jointly developed by The Ganesha Lab and Asociación Chilena de Venture Capital (ACVC). The objective of this meeting between investors and experts in the biotech area was to deepen the investment in biotechnology, the difficulties it presents, its opportunities, and how to overcome barriers in the...
Read More
The two days of the Co-Investment Latam Series ended with total success. The third version of this event participated around 80 investors, who listened to companies seeking to raise funds in two rounds; pre-seed and seed, and series A. The event, organized by the Chilean Association of Venture Capital (ACVC), ARCAP (Argentine Association of Private...
Read More
Once again, the ACVC joined ARCAP (Argentine Association of Private Capital, Entrepreneur and Seed), PECAP (Peruvian Association of Seed and Entrepreneur Capital), and ColCapital – Colombian Association of Private Capital to carry out investment rounds to generate cross border deals. In the third version of the Co-Investment Latam Series, 16 startups from the portfolios of...
Read More
The three days of investment rounds of the Asociación Chilena Venture Capital were successful. Twenty startups presented their pitch to eight of the association’s partner funds and four newly affiliated companies that work with startups. The demo day had the presentation of Matchetune, Luyef Biotechnologies, ROCKWINES, Bravo Heroes, EMONK, Uroboros, MedX, Soleit.app, Grace, Fourdplan, UROFF,...
Read More
“The next NotCo will go before Chile if the candidates do not address these issues,” said Francisco Guzmán, president of the Asociación Chilena de Venture Capital, to La Segunda, referring to the obstacles to entrepreneurship that exist in the country. The interview delves into an eventual strategy to not slow down the momentum that Chilean...
Read More
1 2 3 8

About ACVC

The association seeks to promote the venture capital industry in Chile by encouraging entrepreneurial financing and innovation. Promoting innovation and entrepreneurship since its financing is one of the main objectives set by the new Chilean Venture Capital Association, which aims to become a spokesperson vis-à-vis government entities, investors and other industry players.

Previous Next
Close
Test Caption
Test Description goes like this